Search This Blog

Monday, March 2, 2020

AnaptysBio EPS beats by $0.45, beats on revenue

AnaptysBio (NASDAQ:ANAB): Q4 GAAP EPS of -$0.75 beats by $0.45.
Revenue of $3M beats by $1M.
Press Release
https://seekingalpha.com/news/3547408-anaptysbio-eps-beats-0_45-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)